C5AR2

Chr 19

complement C5a receptor 2

Also known as: C5L2, GPF77, GPR77

This gene encodes a G-protein coupled receptor 1 family member involved in the complement system of the innate immune response. Unlike classical G-protein coupled receptors, the encoded protein does not associate with intracellular G-proteins. It may instead modulate signal transduction through the beta-arrestin pathway, and may alternatively act as a decoy receptor. This gene may be involved in coronary artery disease and in the pathogenesis of sepsis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2012]

OMIMResearchGenerating clinical summary…
MultiplemechanismLOEUF 1.35
Clinical SummaryC5AR2
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.30) despite low pLI — interpret in context.
📋
ClinVar Variants
73 VUS of 90 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.35LOEUF
pLI 0.246
Z-score 1.19
OE 0.30 (0.101.35)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.15Z-score
OE missense 1.03 (0.921.15)
214 obs / 208.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.30 (0.101.35)
00.351.4
Missense OE?1.03 (0.921.15)
00.61.4
Synonymous OE?1.09
01.21.6
LoF obs/exp: 1 / 3.4Missense obs/exp: 214 / 208.1Syn Z: -0.73

This gene — mechanism propensity

DN
0.6937th %ile
GOF
0.73top 25%
LOF
0.2679th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

90 submitted variants in ClinVar

Classification Summary

VUS73
Likely Benign10
Benign4
Conflicting1
73
VUS
10
Likely Benign
4
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
0
0
0
Likely Pathogenic
0
0
0
0
0
VUS
0
73
0
0
73
Likely Benign
0
7
0
3
10
Benign
0
2
0
2
4
Conflicting
1
Total0820588

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

6 pathogenic / likely-pathogenic (of 10) ClinVar copy-number / structural variants overlap C5AR2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

C5AR2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →